Page 17 - IMO-1-1
P. 17

Innovative Medicines & Omics                                         Antioxidant nanomedicines for therapies




            A













            B































            Figure 8. (A and B) Schematic illustration for the synthesis of antithrombotic nanomedicine and its mechanism in treating deep vein thrombosis during
            pregnancy. Reproduced with permission from Cheng et al.  Copyright © 2022, Nature Publishing Group.
                                                 147
            steroidal anti-inflammatory drugs and disease-modifying   bind folate receptor  β overexpressed on M1 macrophages
            antirheumatic drugs have been used for treating    in  arthritic  regions,  enabling  actively  targeting  capability.
            rheumatoid arthritis, but their efficacies are not desirable   The DNA origami can act as a reactant to neutralize ROS,
            due to low bioavailability. 155                    facilitating  the  transition  of  M1  macrophages  to  anti-
              It  has  been  reported  that  the  leaky  vasculatures  in  the   inflammatory M2 phenotype, normalizing the expressions of
            sites of inflamed joints enable nanoparticles to accumulate   associated cytokines, and finally alleviating cartilage damage.
            passively through EPR effect as well as immune cell-enabled   Xu et al. also reported a Mg nanoparticle that can react with
            translocation.  This unique biological mechanism was also   H O to generate H  for ROS-scavenging in arthritic regions. 159
                      154
                                                                             2
                                                                2
            defined in some literatures as “extravasation through leaky   Antioxidant  nanocatalysts  have  also  been  used  for
            vasculature  and  subsequent  inflammatory  cell-mediated   rheumatoid  arthritis  therapy.  The  anti-inflammatory
            sequestration effect”.  Therefore, antioxidant nanomedicines   property of CeO  nanoparticles has been extensively
                           156
            can  accumulate  at  the  regions  affected  by  rheumatoid   demonstrated, 160,161 2  and Kim  et al. constructed CeO -
                                                                                                            2
            arthritis and mitigate oxidative stress, thus modulating the   loading  MSNs  for  treating  rheumatoid  arthritis.  They
                                                                                                       162
                                                         157
            inflammatory  microenvironment  for  efficient  treatment.    used  an  adjuvant-induced  arthritis  rat  model,  which
            Recently, Ma  et al.  used  a  triangular  DNA  origami  as  an   recapitulates the pathologic features of human rheumatoid
            antioxidant antiarthritic nanomedicine (Figure 9).  In this   arthritis,  for  evaluating  the  therapeutic  efficacy.   Paw
                                                   158
                                                                                                       163
            work, DNA origami was modified with folic acid, which can   swelling was significantly reduced after therapy, and
            Volume 1 Issue 1 (2024)                         11                               doi: 10.36922/imo.2527
   12   13   14   15   16   17   18   19   20   21   22